InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Kenny John P., Chairman & CEO. Officer active across 1 companies, notably Meridian Bioscience INC. In total, 6 reports have been published. The latest transaction was filed on 24 June 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
€130,17513,559 shares@ €9.60070.17% mcap17.5% of flow
Common Stock
SEC:0001127602-22-018184:0·
€612,86644,651 shares@ €13.72570.80% mcap82.5% of flow
Common Stock
SEC:0001127602-22-018097:0·
155,511 shares
Common Stock
SEC:0001127602-21-029297·
155,511 shares
Common Stock
SEC:0001127602-21-029297:0·
056,472 shares0
Common Stock
SEC:0001127602-21-028572·
056,472 shares0
Common Stock
SEC:0001127602-21-028572:0·
6 of 6 declarations
About Kenny John P.
John P. Kenny is the Chief Executive Officer of Meridian Bioscience Inc. He leads the company by defining growth strategies and overseeing operations. With a strong background in the industry, he is responsible for innovation and profitability, thereby contributing to Meridian Bioscience's leadership position in the market.
